These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2894233)
1. Response to deoxycoformycin in T cell leukaemias. Catovsky D; Dearden C Br Med J (Clin Res Ed); 1988 Jan; 296(6618):356. PubMed ID: 2894233 [No Abstract] [Full Text] [Related]
2. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia]. Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324 [No Abstract] [Full Text] [Related]
3. Response to deoxycoformycin in mature T cell malignancies. Ho AD; Stryckmans P; Zittoun R Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1483-4. PubMed ID: 3500754 [No Abstract] [Full Text] [Related]
4. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas. Spiers AS Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115 [No Abstract] [Full Text] [Related]
5. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF). Spiers AS; Parekh SJ Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498 [No Abstract] [Full Text] [Related]
6. Membrane phenotype and response to deoxycoformycin in mature T cell malignancies. Dearden CE; Matutes E; Hoffbrand AV; Ganeshaguru K; Brozovic M; Williams HJ; Traub N; Mills M; Linch DC; Catovsky D Br Med J (Clin Res Ed); 1987 Oct; 295(6603):873-5. PubMed ID: 2890401 [TBL] [Abstract][Full Text] [Related]
8. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia. Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382 [No Abstract] [Full Text] [Related]
9. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies. Spiers AS Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090 [TBL] [Abstract][Full Text] [Related]
14. Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin. Brito-Babapulle F; Huang D; Lavender P; Galton D; Catovsky D Eur J Haematol; 1988 Feb; 40(2):185-7. PubMed ID: 3257929 [TBL] [Abstract][Full Text] [Related]
15. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850 [TBL] [Abstract][Full Text] [Related]
16. What is the choice of treatment for hairy cell leukemia? Golomb HM; Ratain MJ; Moormeier J J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730 [No Abstract] [Full Text] [Related]
17. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin). Riddell S; Johnston JB; Rayner HL; Israels LG Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084 [No Abstract] [Full Text] [Related]
18. T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin). Spiers AS; Davis MP; Levine M; Li CY; Mangan KF; Mazza JJ; Neu LT; O'Brien J; Rauch AE; Wiltsie JC Scand J Haematol; 1985 Jan; 34(1):57-67. PubMed ID: 2578689 [TBL] [Abstract][Full Text] [Related]
19. Deoxycoformycin in the treatment of leukemias and lymphomas. Smyth JF; Prentice HG; Proctor S; Hoffbrand AV Ann N Y Acad Sci; 1985; 451():123-8. PubMed ID: 3878113 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials in hairy cell leukemia. Current status and future directions. Cheson BD; Martin A Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]